Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Lancet Oncol. 2020 Feb 14;21(3):436–445. doi: 10.1016/S1470-2045(19)30818-6

Table 3:

Acute ovarian failure risk categories and cases as predicted by the best prescribed dose model

Risk Category Cohort Survivors (n) AOF Cases (n) AOF %
Low (< 5%) CCSS 4,898 117 2·4
SJLIFE 709 1 0·1
Medium Low (5% – < 20%) CCSS 515 62 12·0
SJLIFE 114 26 22·8
Medium (20% – < 50%) CCSS 376 113 30·1
SJLIFE 39 17 43·6
High (≥ 50%) CCSS 97 61 62·9
SJLIFE 13 6 46·2

Abbreviations: AOF is acute ovarian failure, CCSS is the Childhood Cancer Survivor Study, and SJLIFE is the St. Jude Lifetime Cohort.